“Get it right, make it safe!” – This was the theme of World Patient Safety Day 2024, and TASK Research Academy focused on the critical topics of pharmacokinetics, pharmacovigilance and safety management in clinical trials. Ensuring participant safety is paramount in every trial you design, set up, and conduct.

This webinar will take you through the comprehensive safety systems and processes we implement at every stage of a clinical trial—from pre-trial to post-trial—so you can grasp the full scope of what it means to truly “get it right, and make it safe” for our participants and the public.

Expert Insights: Listen to insights from top experts dedicated to safeguarding participants in clinical research.

The Bigger Picture: Develop a comprehensive understanding of pharmacovigilance and participant safety management throughout the entire clinical trial life-cycle.

Actionable Strategies: How to “get it right”. Learn about the various processes, systems and elements, like pharmacokinetics, built into Phase 0 – IV trials,  to manage participant safety oversight.

Medical Doctor and Public Health Medicine Specialist (FCPHM-SA) Founder: Thase Consulting

A distinguished Medical Doctor and Public Health Medicine Specialist, Dr. Azwi Takalani brings a wealth of experience in medical monitoring and pharmacovigilance. As the founder of Thase Consulting and the Sub-Saharan Africa Program Lead at the HIV Vaccines Trial Network, Dr. Takalani’s expertise is unmatched. She has authored numerous articles in prestigious medical journals, making her a leading authority in clinical development and safety.

As a postdoctoral researcher at the University of Cape Town, Dr. Hyke Waalewijn is at the forefront of paediatric pharmacology. His groundbreaking work in improving children’s healthcare, particularly in the context of HIV treatment, has made significant impacts on global health. His contributions to WHO projects and the European AIDS Clinical Society’s paediatric HIV treatment guidelines are just a few examples of his dedication to making healthcare safer for vulnerable populations.